Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd R Burmester

Showing results (261-270 of 293) with videos related to

Pageof 30
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|December 28, 2021
B Cell Numbers Predict Humoral and Cellular Response Upon SARS-CoV-2 Vaccination Among Patients Treated With RituximabAna-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier, et al.
Annals of the Rheumatic Diseases|September 15, 2022
2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid workAnnelies Boonen, Casper Webers, Maarten Butink, et al.
Science Immunology|June 16, 2021
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patientsHector Rincon-Arevalo, Mira Choi, Ana-Luisa Stefanski, et al.
Arthritis and Rheumatism|September 2, 2008
Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countriesTuulikki Sokka, Merete Lund Hetland, Heidi Mäkinen, et al.
Annals of the Rheumatic Diseases|December 17, 2016
2016 update of the EULAR recommendations for the management of early arthritisBernard Combe, Robert Landewe, Claire I Daien, et al.
The Lancet. Rheumatology|June 26, 2025
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 studyAndreas Hess, Koray Tascilar, Hanna M Schenker, et al.
Annals of the Rheumatic Diseases|February 6, 2021
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19Alessia Alunno, Aurélie Najm, Pedro M Machado, et al.
Annals of the Rheumatic Diseases|May 30, 2024
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) RegistryBayram Farisogullari, Saskia Lawson-Tovey, Kimme L Hyrich, et al.
Rheumatology International|August 15, 2013
German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugsKatinka Albrecht, Klaus Krüger, Jürgen Wollenhaupt, et al.
Annals of the Rheumatic Diseases|January 6, 2018
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritisHelga Radner, Katerina Chatzidionysiou, Elena Nikiphorou, et al.
Pageof 30

Showing results (261-270 of 293) with videos related to

Sort By:
Pageof 30
Arthritis & Rheumatology (Hoboken, N.J.)|December 28, 2021
B Cell Numbers Predict Humoral and Cellular Response Upon SARS-CoV-2 Vaccination Among Patients Treated With RituximabAna-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier, et al.
Annals of the Rheumatic Diseases|September 15, 2022
2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid workAnnelies Boonen, Casper Webers, Maarten Butink, et al.
Science Immunology|June 16, 2021
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patientsHector Rincon-Arevalo, Mira Choi, Ana-Luisa Stefanski, et al.
Arthritis and Rheumatism|September 2, 2008
Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countriesTuulikki Sokka, Merete Lund Hetland, Heidi Mäkinen, et al.
Annals of the Rheumatic Diseases|December 17, 2016
2016 update of the EULAR recommendations for the management of early arthritisBernard Combe, Robert Landewe, Claire I Daien, et al.
The Lancet. Rheumatology|June 26, 2025
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 studyAndreas Hess, Koray Tascilar, Hanna M Schenker, et al.
Annals of the Rheumatic Diseases|February 6, 2021
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19Alessia Alunno, Aurélie Najm, Pedro M Machado, et al.
Annals of the Rheumatic Diseases|May 30, 2024
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) RegistryBayram Farisogullari, Saskia Lawson-Tovey, Kimme L Hyrich, et al.
Rheumatology International|August 15, 2013
German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugsKatinka Albrecht, Klaus Krüger, Jürgen Wollenhaupt, et al.
Annals of the Rheumatic Diseases|January 6, 2018
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritisHelga Radner, Katerina Chatzidionysiou, Elena Nikiphorou, et al.
Pageof 30